Anupam Rasayan India Limited (ARIL), a domestic company engaged in the business of custom synthesis and specialty chemical manufacturing, announced this morning that it has secured two contracts worth Rs 540 crore from two esteemed multinational companies.  

Adani Green Energy Limited (AGEL), a leading renewable energy company announced this morning that it has entered into a share purchase agreement with SB Energy Holdings Limited (SB Energy India) for complete acquisition of the latter.   

Kolte-Patil Developers Limited, a real estate company based in Pune, announced this morning that it has signed two new projects in Hinjewadi and Tathawade areas in Pune.

Alembic Pharmaceuticals Limited, a leading pharmaceutical company, announced today that it has received approval from US Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Lurasidone Hydrochloride tablets (20 mg, 40 mg, 60 mg, 80 mg, and 120 mg).  

Sun Pharma Advanced Research Company Ltd (SPARC), a global pharmaceutical company announced on Friday that it has achieved success in phase 3 trial of its investigational drug namely, PDP-716 ophthalmic suspension.   

ITD Cementation India Limited, a domestic construction engineering company, announced this afternoon that it has secured two orders worth Rs 950 crore.   

Cadila Healthcare Ltd, a global pharmaceutical company, announced today that its wholly-owned subsidiary, Zydus Animal Health & Investments Limited (ZAHL) has entered into a business transfer agreement (BTA) to sell & transfer its animal healthcare established markets undertaking (Zydus AH) to a consortium, which is led by Multiples Alternate Asset Management.

Suumaya Industries Ltd, a domestic company, which is engaged in the business of garment manufacturing for women, announced this morning that it has forayed into agri-trading business during March quarter of FY21.  

JSW Steel Ltd, one of the leading integrated steel companies in India, announced this morning that it has signed a memorandum of understanding (MoU) to undertake a feasibility test with JFE Steel Corporation, a strategic alliance partner.   

JB Chemicals & Pharmaceuticals Ltd (JBCPL), a domestic pharmaceutical company, announced this afternoon that it has forayed into the nephrology segment by launching a new dedicated division called 'Renova'.